Targeted therapies and immunotherapy are improving leukemia survival rates, offering renewed hope for more effective treatments and potential cures.

The first oncology clinical trial is under way at the Albany Health Campus Cancer Centre, giving local patients access to new and innovative genetic...

Oncology is evolving fast as immunotherapy, AI and targeted drugs expand treatment options, boost outcomes, and fuel long-term healthcare growth.

Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer...

Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer...

Highlights: Targeted therapies and immunotherapy are improving leukemia survival rates Some leukemia types now

Vitamin B2 (riboflavin) metabolism helps cancer cells evade ferroptosis, offering new avenues for targeted cancer therapies.

Vitamin B2 (riboflavin) metabolism helps cancer cells evade ferroptosis, offering new avenues for targeted cancer therapies.

DelveInsight's "Microsatellite Stable Colorectal Cancer Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth...

World Down Syndrome Day on March 21 highlights Trisomy 21, a genetic condition affecting millions. While biology is understood, outcomes depend on...